UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Retained Earnings	Accumulated Other Comprehensive Income (Loss)
Beginning balance (in shares) at Dec. 31, 2022		24,402,891
Beginning balance at Dec. 31, 2022	$ 1,635,790	$ 244	$ 1,510,924	$ 159,690	$ (35,068)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,632		5,632	0
Exercise of stock options, net (in shares)		1,322
Exercise of stock options	55		55
Issuance of restricted stock, net (in shares)		187,162
Issuance of restricted stock, net	(5,019)	$ 2	(5,021)
Common stock dividends	(14,769)			(14,769)
Foreign currency translation adjustment	(9,340)				(9,340)
Unrealized gains on marketable securities, net of tax	108				108
Net (loss) income	(2,028)			(2,028)
Ending balance (in shares) at Mar. 31, 2023		24,591,375
Ending balance at Mar. 31, 2023	$ 1,610,429	$ 246	1,511,590	142,893	(44,300)
Beginning balance (in shares) at Dec. 31, 2023	24,406,816	24,406,816
Beginning balance at Dec. 31, 2023	$ 1,652,518	$ 244	1,517,650	168,871	(34,247)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	5,329		5,329	0
Exercise of stock options, net (in shares)		2,236
Exercise of stock options	145		145
Issuance of restricted stock, net (in shares)		198,887
Issuance of restricted stock, net	(3,831)	$ 2	(3,833)
Common stock dividends	(14,773)			(14,773)
Foreign currency translation adjustment	(26,650)				(26,650)
Unrealized gains on marketable securities, net of tax	143				143
Net (loss) income	$ 29,702			29,702
Ending balance (in shares) at Mar. 31, 2024	24,607,939	24,607,939
Ending balance at Mar. 31, 2024	$ 1,642,583	$ 246	$ 1,519,291	$ 183,800	$ (60,754)